Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Kranjc, Zofija
DOB: 16-JUN-1941 (Age: 84)
Gender: female
ID: 8388-709159-9 (ECI)
Author
Lebar, Josip
Patient summary Document
European Patient Summary
Report Date: 22-JUL-2025

Problem list

Condition Onset Date / Period Status
Acute viral pharyngitis 15-Jul-2025 active
Chronic congestive heart failure 12-Aug-2023 active
Mitral valve regurgitation 26-Apr-2017 active
Alzheimer's disease 25-Apr-2017 active
Pulmonary emphysema 07-Jan-2014 active
Idiopathic atrophic hypothyroidism 10-Aug-2002 active
Neuropathy due to type 2 diabetes mellitus 24-Oct-2000 active
Substance dependence 18-Jun-1995 active
Impacted molars 04-Aug-1991 active
Chronic intractable migraine without aura 01-Feb-1990 active
Ischemic heart disease 22-Aug-1989 active
Hyperglycemia 16-Aug-1988 active
Metabolic syndrome X 30-Jul-1985 active
Hypertriglyceridemia 30-Jul-1985 active
Type 2 diabetes mellitus 24-Jul-1984 active
Essential hypertension 19-Mar-1963 active
Overdose 29-Apr-2024 - 29-Apr-2024 inactive
Viral sinusitis 14-Jan-2020 - 10-Feb-2020 inactive
Overdose 29-Dec-2018 - 29-Dec-2018 inactive
Acute bronchitis 09-Jul-2018 - 21-Jul-2018 inactive
Viral sinusitis 08-Aug-2017 - 25-Aug-2017 inactive

Medication list

Medication Since Form Dosage Reason
60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler 2025-07-22 - 1 inhalation (250 mcg/50 mcg) twice daily Pulmonary emphysema (disorder)
Carvedilol 25 mg oral tablet 2025-07-22 - 1 tablet (25 mg) twice daily Chronic congestive heart failure (disorder)
Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation 2025-07-22 - 2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 6 hours as needed Pulmonary emphysema (disorder)
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-07-22 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Furosemide 40 mg oral tablet 2025-07-22 - 1 tablet (40 mg) by mouth once daily Chronic congestive heart failure (disorder)
Lisinopril 10 mg oral tablet 2025-07-22 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 20 mg oral tablet 2025-07-22 - 1 tablet (20 mg) by mouth once daily Chronic congestive heart failure (disorder)
Metformin hydrochloride 500 mg prolonged-release oral tablet 2025-07-22 - 1 tablet (500 mg) once daily Diabetes mellitus type 2 (disorder)
Losartan potassium 50 mg oral tablet 2025-07-22 - 1 tablet (50 mg) by mouth once daily Chronic congestive heart failure (disorder)
Galantamine (as galantamine hydrobromide) 4 mg oral tablet 2017-04-25 - 1 tablet (4 mg) once daily Alzheimer's disease (disorder)
Levothyroxine sodium anhydrous 75 microgram oral tablet 2002-08-10 - 1 tablet (75 microgram) once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 1989-08-29 - 1 spray (400 micrograms) under the tongue as needed for chest pain, repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 1989-08-29 - 1 tablet (100 mg) once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 12-Nov-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 19-May-2020

Procedure History list

Procedure Date Reason
Pulmonary rehabilitation 10-Jun-2025 Pulmonary emphysema (disorder)
Spirometry 10-Jun-2025 Pulmonary emphysema (disorder)
Depression screening 10-Jun-2025 -
Assessment of health and social care needs 10-Jun-2025 -
Assessment of anxiety 10-Jun-2025 -
Assessment using Morse Fall Scale 10-Jun-2025 -
Heart failure education 23-Aug-2024 Chronic congestive heart failure (disorder)
Oxygen administration by mask 22-Aug-2024 -
Placing subject in prone position 22-Aug-2024 -
Electrocardiographic procedure 21-Aug-2024 Chronic congestive heart failure (disorder)
Echocardiography 21-Aug-2024 -
Plain X-ray of chest 21-Aug-2024 -
Medication reconciliation 21-Aug-2024 -
Patient discharge 25-Apr-2024 -
Hospice care 24-Apr-2024 -
Notifications 16-Apr-2024 -
Certification procedure 16-Apr-2024 -
Initial patient assessment 16-Apr-2024 -
Development of individualized plan of care 16-Apr-2024 -
Screening for domestic abuse 24-Oct-2023 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Heart failure self management plan 28-Aug-2023 Chronic congestive heart failure (disorder)
  • Patient will monitor and record weight daily to detect early signs of fluid retention.
  • Patient will limit daily sodium intake to reduce fluid overload risk.
  • Patient will restrict daily fluid intake as recommended to prevent fluid overload.
  • Patient will recognize and promptly report symptoms of heart failure exacerbation such as increased shortness of breath, swelling, or rapid weight gain.
  • Patient will take heart failure medications as prescribed without missed doses.
Dementia management 25-Apr-2017 Alzheimer's disease (disorder)
  • Support and maintain current level of cognitive function and daily living abilities in patient with Alzheimer's disease.
Chronic obstructive pulmonary disease clinical management plan 07-Jan-2014 Pulmonary emphysema (disorder)
  • Patient will abstain from tobacco use to slow progression of pulmonary emphysema.
  • Maintain oxygen saturation at or above 92% on room air or prescribed supplemental oxygen.
  • Reduce acute COPD exacerbations to no more than 1 per year.
  • Patient will be able to walk at least 100 meters without significant dyspnea.
  • Patient will receive annual influenza vaccination and pneumococcal vaccination as recommended.
Care plan 15-May-1994 -
Diabetes self management plan 24-Jul-1984 Diabetes mellitus type 2 (disorder)
  • Maintain HbA1c below 7.5% to reduce risk of diabetes complications.
  • Maintain fasting blood glucose between 80 and 130 mg/dL.
  • Demonstrate understanding of diabetes self-care including medication, diet, and symptom monitoring.
Lifestyle education regarding hypertension 19-Mar-1963 Essential hypertension (disorder)
  • Patient will receive education on lifestyle modifications to help control blood pressure, including diet, exercise, and medication adherence.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-07-22 2025-07-15
Body Height 167.5 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} -
Body Weight 77.1 kg -
Body mass index (BMI) [Ratio] 27.5 kg/m2 -
Heart rate 84 /min -
Respiratory rate 16 /min -
Blood pressure panel with all children optional 32 mm[Hg] -
Body temperature - 37.8 Cel

Relevant diagnostic tests/laboratory data

Recent Lab Observations 22-JUL-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.4 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 94.8 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Blood 142.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.9 96 - 106 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.3 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 99.1 L 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 136.0 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 11.4 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.5 40 - 90 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 14.3 0 - 30 mg/g

Device Use

Device Date (since)
Portable oxygen cylinder (physical object) 27-Jun-2023
Oxygen concentrator (physical object) 27-Jun-2023
Blood glucose meter (physical object) 24-Jul-1984